Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Acutus Medical Inc (NQ: AFIB )

0.9800 UNCHANGED
Streaming Delayed Price Updated: 3:59 PM EDT, May 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.9800
Bid (Size) 0.6500 (100)
Ask (Size) 1.470 (50)
Prev. Close 0.9800
Today's Range 0.9800 - 0.9800
52wk Range 0.4800 - 2.150
Shares Outstanding 34,607,593
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Acutus Medical to Showcase Innovative Cardiac Mapping and Ablation Technologies at HRS 2023
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical: Q1 Earnings Insights
 
Via Benzinga

Performance

YTD
-29.50%
-29.50%
1 Month
+4.22%
+4.22%
3 Month
-36.77%
-36.77%
6 Month
+23.39%
+23.39%
1 Year
+41.52%
+41.52%

More News

Read More
Acutus Medical Reports First Quarter 2023 Financial Results
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical's Earnings: A Preview
Via Benzinga
Looking Into Acutus Medical's Return On Capital Employed
Via Benzinga
Acutus Medical to Announce First Quarter 2023 Financial Results
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Preliminary Unaudited First Quarter 2023 Results
From Acutus Medical, Inc.
Via GlobeNewswire
RECOVER AF Study Reports 91% of First Redo Patients Achieved Freedom from AF at One Year After AcQMap-guided Ablation Therapy
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Reports Fourth Quarter and Full Year 2022 Financial Results
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical to Announce Fourth Quarter and Full Year 2022 Financial Results
From Acutus Medical, Inc.
Via GlobeNewswire
Why Hertz Global Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Late-Breaking ACQFORCE FLUTTER Trial Meets Primary Endpoint for Safety and Efficacy with the First Gold-Tipped Contact Force Sensing Ablation Catheter
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Results and Appointment of Chief Financial Officer
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Acceptance of the AcQForce Flutter Abstract for Presentation during the Late-Breaking Clinical Trials and First Report Investigations sessions at the 2023 AF Symposium
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Achieves EU MDR Submission Milestone in Sale of Left-Heart Access Portfolio to Medtronic
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Full Market Release of next generation software platform AcQMap 8.5
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Obtains MDR CE Mark of the AcQMap 3D Imaging and Mapping Catheter
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Reports Third Quarter 2022 Financial Results
From Acutus Medical, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.